Skip to main content

Table 3 Characteristics of patients with Facioscapulohumeral muscular dystrophy type 1 (FSHD1) at follow-up

From: Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study

 

Presence of Late Gadolinium Enhancement

All (n = 40)

No (n = 26)

Yes (n = 14)

Age (years)

49 ± 14

47 ± 14

54 ± 11

Male sex, n (%)

29 (70.7)

9 (36)

3 (21.4)

Heart rate (beats per minute)

74 ± 13

76 ± 13

71 ± 14

Systolic BP (mmHg)

129 ± 15

127 ± 16

132 ± 15

Diastolic BP (mmHg)

79 ± 10

79 ± 9

79 ± 11

Arterial hypertension, n (%)

8 (20)

1

7

Hyperlipidemia, n (%)

7 (17.5)

3

4

Diabetes mellitus, n (%)

3 (7.5)

1

2

Smoking, n (%)

5 (12.5)

3

2

Cardiac symptoms

 Asymptomatic, n (%)

29 (70.7)

19

10

 Palpitations, n (%)

8 (12.2)

6

2

 Chest pain, n (%)

1(2.4)

1

0

 Fatigue, n (%)

6 (14.6)

4

2

  1. Data are shown as mean values ± standard deviation (SD) according to the AHA-segment model. BP blood pressure